Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ABLLW
Upturn stock ratingUpturn stock rating

Abacus Life Inc. (ABLLW)

Upturn stock ratingUpturn stock rating
$1.29
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/13/2025: ABLLW (3-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Number of Analysts

rating

0 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

Analysis of Past Performance

Type Stock
Historic Profit 232.51%
Avg. Invested days 49
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 5.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/13/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta -
52 Weeks Range 0.46 - 1.90
Updated Date 02/26/2025
52 Weeks Range 0.46 - 1.90
Updated Date 02/26/2025
Dividends yield (FY) -
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating -
Shares Outstanding -
Shares Floating -
Percent Insiders -
Percent Institutions -

ai summary icon Upturn AI SWOT

Abacus Life Inc.

stock logo

Company Overview

overview logo History and Background

Abacus Life, Inc. was founded in 2004 and is headquartered in Orlando, Florida. It is a specialty finance company focused on purchasing life insurance policies from seniors. It became a publicly traded company through a business combination with East Resources Acquisition Company in June 2023.

business area logo Core Business Areas

  • Life Settlements: Abacus Life is a buyer, originator, and servicer of life settlements, which are life insurance policies purchased from individuals for a lump sum payment. They focus on acquiring policies, managing them, and eventually collecting the death benefit.

leadership logo Leadership and Structure

Jay Jackson serves as the Chief Executive Officer. The company has a board of directors overseeing its operations.

Top Products and Market Share

overview logo Key Offerings

  • Life Settlement Purchases: Abacus Life's primary product is the purchase of life insurance policies from individuals, providing immediate liquidity in exchange for the future death benefit. Market share data is difficult to pinpoint exactly, but Abacus is considered a large player in this fragmented market with significant market share. Competitors include GWG Holdings (in bankruptcy), Coventry First, and Lighthouse Life.

Market Dynamics

industry overview logo Industry Overview

The life settlement industry involves the purchase of existing life insurance policies from policyholders. It is a growing market driven by aging populations, increasing healthcare costs, and the desire for alternative financial solutions. The market is regulated at the state level.

Positioning

Abacus Life positions itself as a leading purchaser and servicer of life settlements. Their competitive advantage lies in their experience, capital base, and servicing platform, which enable them to efficiently manage and monetize life insurance policies.

Total Addressable Market (TAM)

The total addressable market for life settlements is estimated to be in the billions of dollars annually. Abacus Life is positioned to capture a significant portion of this market through its expertise and established network.

Upturn SWOT Analysis

Strengths

  • Established platform
  • Experienced management team
  • Strong capital base
  • Proprietary pricing models

Weaknesses

  • Reliance on life insurance policies
  • Regulatory risk
  • Sensitivity to interest rate changes
  • Competition in policy acquisition

Opportunities

  • Growing aging population
  • Increasing awareness of life settlements
  • Potential for expansion into new markets
  • Acquisitions of smaller competitors

Threats

  • Changes in mortality rates
  • Increased regulation
  • Economic downturn affecting policy values
  • Litigation risk related to policy ownership

Competitors and Market Share

competitor logo Key Competitors

  • CODI
  • LFC
  • TSE:8793

Competitive Landscape

Abacus Life benefits from its size and scale, allowing it to compete effectively in the life settlement market. However, it faces competition from other established players and new entrants.

Major Acquisitions

Longevity Market Assets, LLC

  • Year: 2023
  • Acquisition Price (USD millions): 32
  • Strategic Rationale: The acquisition broadened Abacus's origination capabilities and expanded its access to life settlement policies.

Growth Trajectory and Initiatives

Historical Growth: Historical growth has been substantial as the life settlement market expands. More specific growth rates are difficult to source. However, Abacus touts itself as a leader in the market.

Future Projections: Future growth is projected to be positive, driven by the aging population and increasing awareness of life settlements. Analyst estimates are not widely available.

Recent Initiatives: Abacus Life has focused on expanding its origination network and investing in technology to improve its operational efficiency.

Summary

Abacus Life is a leading player in the growing life settlement market, leveraging its expertise and platform to acquire and manage life insurance policies. While it faces regulatory and economic risks, the company is well-positioned to capitalize on the increasing demand for alternative financial solutions. Its future success depends on its ability to navigate the competitive landscape and manage its operational risks effectively. Abacus Life's strong capital position and leadership in the life settlement industry point towards positive growth, although interest rate sensitivity needs monitoring.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings
  • Company website
  • Industry reports

Disclaimers:

This analysis is based on available information and should not be considered financial advice. Investment decisions should be made in consultation with a qualified financial advisor.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Abacus Life Inc.

Exchange NASDAQ
Headquaters -
IPO Launch date 2023-07-05
CEO -
Sector Financial Services
Industry Insurance - Life
Full time employees 82
Website
Full time employees 82
Website

Abacus Life, Inc. operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.